UK markets closed

Valneva SE (0OB3.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
6.55-0.16 (-2.43%)
At close: 05:58PM GMT
Full screen
Previous close6.72
Open6.70
Bid0.00 x 0
Ask0.00 x 0
Day's range6.49 - 6.70
52-week range6.49 - 6.70
Volume27,470
Avg. volumeN/A
Market cap5.882M
Beta (5Y monthly)1.30
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Valneva Appoints Dipal Patel as Chief Commercial Officer

    Saint-Herblain (France), November 17, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dipal Patel as Chief Commercial Officer (CCO) and Management Board member. With this newly created role, Valneva strengthens its management team with a recognized commercial industry leader as the Company advances its chikungunya vaccine candidate towards potential market entry in 2023. Ms. Patel is an established commercial leader with over

  • Globe Newswire

    Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates

    Total nine-month revenues of €249.9 million, a ~ 3.5-fold increase compared to 2021 Product sales of €74.4 million (vs €45.5 million in the first nine months of 2021) driven by a continued recovery of travel vaccine sales and by COVID-19 vaccine sales in Europe. Product sales outside of COVID-19 grew by double digits (11.2%) vs. prior period€175.5 million of other revenues (vs €24.4 million in the first nine months of 2021) mainly driven by revenue recognition related to previous COVID-19 vaccin

  • Globe Newswire

    Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference

    Saint-Herblain (France), November 7, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its Chief Executive Officer Thomas Lingelbach and Chief Financial Officer Peter Bühler will present and participate in 1-on-1 meetings with institutional investors at the Jefferies London Healthcare Conference, to take place November 15-17, 2022 in London, England. Additionally, Mr. Lingelbach and Mr. Bühler will participate in a fireside chat on Tuesday,